Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Linkoeping
About this trial
The purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 months postoperatively and the patency will be evaluated with coronary computed tomography angiography (CCTA)
Eligibility criteria
Qualifiers
Previously included in TACSI-trial
Disqualifiers
Highly irregular heart rhythm (i.e. atrial fibrillation)
Chronic kidney disease with estimated glomerular filtration rate (eGFR) <45ml/min/1,73m2
Body weight >120 kg
Previous severe allergic reaction (i.e. anaphylactic reaction) to iodine-based contrast agents
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov